ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

VERU Veru Inc

1.45
-0.18 (-11.04%)
May 08 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 3,313,229
Bid Price 1.41
Ask Price 1.45
News (3)
Day High 1.6399

Low
0.36

52 Week Range

High
1.92

Day Low 1.30
Company Name Stock Ticker Symbol Market Type
Veru Inc VERU NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.18 -11.04% 1.45 20:00:00
Open Price Low Price High Price Close Price Prev Close
1.41 1.30 1.6399 1.43 1.63
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
10,769 3,313,229 $ 1.48 $ 4,896,335 - 0.36 - 1.92
Last Trade Time Type Quantity Stock Price Currency
19:59:06 95 $ 1.45 USD

Veru Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
207.86M 146.38M - 16.3M -93.09M -0.64 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Veru News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No VERU Message Board. Create One! See More Posts on VERU Message Board See More Message Board Posts

Historical VERU Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.381.751.301.602,871,3300.075.07%
1 Month1.141.921.001.513,922,0850.3127.19%
3 Months0.3851.920.3700011.132,538,6901.07276.62%
6 Months1.021.920.360.90948012,096,0190.4342.16%
1 Year1.341.920.360.97026471,634,0410.118.21%
3 Years7.8524.550.3610.344,378,945-6.40-81.53%
5 Years1.5524.560.3610.193,262,297-0.10-6.45%

Veru Description

Veru Inc is a biopharmaceutical company focused on urology and oncology. It develops prescription products for benign prostatic hyperplasia hot flashes associated with cancer treatment, male infertility, and novel chemotherapies for a variety of cancers. The company currently operates in two reporting segments: Sexual health business and Research & development. Some of its products include Zuclomiphene, Veru-111, Veru-100, FC2, and Roman Swipes. The company generates the majority of its revenue from the United States.

Your Recent History

Delayed Upgrade Clock